Haifa, Israel

Ziv Dee Noor

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Tenova Advanced Technologies Ltd, Teva Pharmaceutical Industries Limited. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ziv Dee Noor. Retrieved from https://idiyas.com/inventor/ziv-dee-noor-xu9221da

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ziv Dee Noor: Innovator in Pharmaceutical Chemistry

Introduction

Ziv Dee Noor is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for drug preparation.

Latest Patents

Ziv Dee Noor holds a patent for a "Method for the preparation of Pregabalin and salts thereof." This patent outlines processes for preparing and purifying Pregabalin, a medication used to treat various conditions, including neuropathic pain and epilepsy.

Career Highlights

Ziv is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has focused on innovative approaches to drug formulation and development.

Collaborations

Ziv has collaborated with talented professionals such as Lilach Hedvati and Claude Singer, contributing to advancements in pharmaceutical research and development.

Conclusion

Ziv Dee Noor's work exemplifies the impact of innovation in the pharmaceutical industry, showcasing his dedication to improving drug preparation methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…